glp 1 drugs and vision loss π Optometrists are warning GLP-1 may pose these types of rare risks π β¬οΈ Details in comments GLP-1 Vision Loss Lawsuit: An
Description
Ozempic dominated the GLP-1 agonists market owing to its high adoption for the management of type 2 diabetes, wide geographic availability, and a strong brand recognition

Direct head-to-head comparisons are not possible because the trials differed in duration, population and study design, but reporting outcomes side-by-side provides context

Are Wegovy and Ozempic the same drug

Acta Diabetol (2020) 57(11):131526

Bastin, M., & Andreelli, F
